JPRN-jRCT2080221611未知1 期
A Phase I/II study of NK012 in patients with multiple myeloma
ippon Kayaku Co., Ltd.0 个研究点目标入组 60 人开始时间: 2011年10月7日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •1.Symptomatic disease thought to require therapy and received therapy at least 2 regimens
- •2.ECOG performance status (P.S.) score of 0-2(include P.S.3 with osteolytic disease)
- •3.Patients who don't have abnormal ECG with therapy
- •4.Patients age 20 to 79 years(inclusive)at time of informed consent
排除标准
- •1.By pharmacogenetic testing, patients who are homozygous for UGT1A1*28 or UGT1A1*6, or those who are simultaneously heterozygous for UGT1A1*28 and UGT1A*6
- •2.Patients who received irinotecan hydrochloride or nogitecan hydrochloride or drugs (include investigational agent) which have same mechanisms of action (type I DNA topoisomerase inhibition)
- •3.Patients who are plasma cell leukemia
- •4.Patients who have active infection
研究者
相似试验
未知
2 期
A phase II study of NK105 for patients with previously treated advanced or recurrent gastric cancer.Gastric cancerJPRN-jRCT2080220741ippon Kayaku Co., Ltd.
招募中
1 期
Phase I study of RO7187797 in patients with Multiple myeloma.Multiple myelomaJPRN-jRCT2061220045anki Toshihiro6
未知
1 期
Phase 1/2 study of NS-065/NCNP-01 in patients with Duchenne muscular dystrophyDuchenne muscular dystrophyJPRN-jRCT2080223236IPPON SHINYAKU CO., LTD.16
未知
2 期
A M117101 phase II study in patients with primary palmar hyperhidrosisprimary palmar hyperhidrosisJPRN-jRCT2080222374Maruho Co.,Ltd.
进行中（未招募）
1 期
Phase II Study of ZK 219477 in patients with recurrent glioblastomaEUCTR2006-001659-37-GBEuropean Organisation for Research and Treatment of Cancer